Skip to content

Effect of Pharmacist Intervention on Urinary Tract Infection Prognosis: A Multicentre, Randomized Clinical Trial

Effect of Pharmacist Intervention on Urinary Tract Infection Prognosis: A Multicentre, Randomized Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126262
Enrollment
Unknown
Registered
2026-06-05
Start date
2026-06-10
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary tract stone

Interventions

Control Group:Medical Care Management
Intervention Group:Clinical Pharmacist Intervention Group

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age 18 years or older; 2. Diagnosed with upper urinary tract stones (kidney stones; ureteral stones); 3. Admitted to the urology department for minimally invasive surgery for upper urinary tract stones; 4. Able to understand and provide the ability to sign an informed consent form;

Exclusion criteria

Exclusion criteria: 1. Patients admitted through the emergency department for stone surgery or ureteral stent placement; 2. Patients with other concurrent infections; 3. Patients undergoing open stone removal surgery; 4. Pregnant or breastfeeding women;

Design outcomes

Primary

MeasureTime frame
The incidence of sepsis;

Secondary

MeasureTime frame
Antibacterial drug DDDs;The incidence rate of SIRS after surgery;length of stay;

Countries

China

Contacts

Public ContactYunting Zhang

Shanghai Tenth People's Hospital

pharmacy2010@163.com+86 21 66303439

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026